Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CALASPARGASE PEGOL for B-cell type acute leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 32 adverse event reports in the FDA FAERS database where CALASPARGASE PEGOL was used for B-cell type acute leukaemia.

Most Reported Side Effects for CALASPARGASE PEGOL

Side Effect Reports % Deaths Hosp.
Hypertriglyceridaemia 27 21.6% 9 24
Febrile neutropenia 19 15.2% 1 17
Hypersensitivity 13 10.4% 1 6
Neutropenia 11 8.8% 1 2
Coagulopathy 10 8.0% 10 10
Hepatotoxicity 10 8.0% 10 10
Renal failure 10 8.0% 9 10
Circulatory collapse 9 7.2% 9 9
Clostridium difficile infection 9 7.2% 9 9
Electrolyte imbalance 9 7.2% 9 9
Gastrointestinal haemorrhage 9 7.2% 9 9
Hypoalbuminaemia 9 7.2% 9 9
Pancytopenia 9 7.2% 9 9
Polyneuropathy 9 7.2% 9 9
Respiratory syncytial virus infection 9 7.2% 9 9

Other Indications for CALASPARGASE PEGOL

Acute lymphocytic leukaemia (48) T-cell type acute leukaemia (9) Supportive care (7)

Other Drugs Used for B-cell type acute leukaemia

METHOTREXATE (925) VINCRISTINE (889) BLINATUMOMAB (622) DEXAMETHASONE (606) CYCLOPHOSPHAMIDE (586) CYTARABINE (582) PEGASPARGASE (374) DOXORUBICIN (360) TISAGENLECLEUCEL (354) MERCAPTOPURINE (308)

Related Pages

CALASPARGASE PEGOL Full Profile All B-cell type acute leukaemia Drugs CALASPARGASE PEGOL Demographics CALASPARGASE PEGOL Timeline